Liquidia Technologies PE Ratio 2018-2020 | LQDA

Current and historical p/e ratio for Liquidia Technologies (LQDA) from 2018 to 2020. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Liquidia Technologies PE ratio as of September 23, 2021 is 0.00.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Liquidia Technologies PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2021-09-23 2.78 0.00
2020-09-30 4.92 $-2.13 0.00
2020-06-30 8.42 $-2.45 0.00
2020-03-31 4.71 $-2.28 0.00
2019-12-31 4.28 $-2.63 0.00
2019-09-30 3.56 $-2.53 0.00
2019-06-30 8.00 $-2.65 0.00
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.145B $0.001B
Liquidia Technologies, Inc. is a late-stage clinical biopharmaceutical company. It focused on the development and commercialization of human therapeutics using our proprietary PRINT technology to transform the lives of patients. The company's product candidate consists of LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain which are in clinical stage. Liquidia Technologies, Inc. is based in NC, United States.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $133.660B 8.90
Bio-Rad Laboratories (BIO.B) United States $23.483B 50.05
QIAGEN (QGEN) Netherlands $12.482B 21.14
Biohaven Pharmaceutical Holding (BHVN) United States $8.764B 0.00
Emergent Biosolutions (EBS) United States $2.892B 6.98
Arcus Biosciences (RCUS) United States $2.573B 0.00
Myovant Sciences (MYOV) United Kingdom $2.051B 0.00
ADC Therapeutics SA (ADCT) Switzerland $2.021B 0.00
Zymeworks (ZYME) Canada $1.443B 0.00
Ambrx Biopharma (AMAM) United States $0.527B 0.00
SQZ Biotechnologies (SQZ) United States $0.417B 0.00
Enzo Biochem (ENZ) United States $0.172B 50.71